Home » Sanofi Rebuffs Renewed Lantus Cancer Worries
Sanofi Rebuffs Renewed Lantus Cancer Worries
A Swedish study has rekindled concerns about a possible link between Sanofi’s top-selling insulin drug Lantus and cancer, but the French drugmaker said Wednesday the observational research was seriously flawed.
Fox News
Fox News
Upcoming Events
-
07May
-
14May
-
30May